These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 7490018)
21. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia]. Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587 [TBL] [Abstract][Full Text] [Related]
22. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men. Kashyap ML; Barnhart RL; Srivastava LS; Perisutti G; Vink P; Allen C; Hogg E; Brady D; Glueck CJ; Jackson RL J Lipid Res; 1982 Aug; 23(6):877-86. PubMed ID: 7130856 [TBL] [Abstract][Full Text] [Related]
24. Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice. Qu S; Perdomo G; Su D; D'Souza FM; Shachter NS; Dong HH J Lipid Res; 2007 Jul; 48(7):1476-87. PubMed ID: 17438339 [TBL] [Abstract][Full Text] [Related]
25. Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects. Cohn JS; Tremblay M; Batal R; Jacques H; Veilleux L; Rodriguez C; Bernier L; Mamer O; Davignon J J Lipid Res; 2002 Oct; 43(10):1680-7. PubMed ID: 12364552 [TBL] [Abstract][Full Text] [Related]
26. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834 [TBL] [Abstract][Full Text] [Related]
27. Apolipoproteins in human pregnancy. Hillman L; Schonfeld G; Miller JP; Wulff G Metabolism; 1975 Aug; 24(8):943-52. PubMed ID: 167266 [TBL] [Abstract][Full Text] [Related]
28. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins. Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727 [TBL] [Abstract][Full Text] [Related]
29. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. Batal R; Tremblay M; Barrett PH; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn JS J Lipid Res; 2000 May; 41(5):706-18. PubMed ID: 10787431 [TBL] [Abstract][Full Text] [Related]
30. Oxidative modification of lipoproteins in hypertriglyceridemic patients and hypercholesterolemic rabbits in vivo. Liu BW; Jiang Y; Fu MD; Liu Y; Fan P Mol Cell Biochem; 2000 Apr; 207(1-2):131-5. PubMed ID: 10888238 [TBL] [Abstract][Full Text] [Related]
31. Lipid and apolipoprotein distribution as a function of density in equine plasma lipoprotein. Le Goff D; Pastier D; Hannan Y; Petit E; Ayrault-Jarrier M; Nouvelot A Comp Biochem Physiol B; 1989; 93(2):371-7. PubMed ID: 2776430 [TBL] [Abstract][Full Text] [Related]
32. Distribution of lipids and apolipoproteins in human plasma by vertical spin ultracentrifugation. Campos E; McConathy WJ Arch Biochem Biophys; 1986 Sep; 249(2):455-63. PubMed ID: 3753012 [TBL] [Abstract][Full Text] [Related]
33. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. Chan DC; Nguyen MN; Watts GF; Barrett PH J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086 [TBL] [Abstract][Full Text] [Related]
34. Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells. Dashti N; Smith EA; Alaupovic P J Lipid Res; 1990 Jan; 31(1):113-23. PubMed ID: 2313196 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy. Cubrilo-Turek M; Sertić J; Duraković Z Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019 [TBL] [Abstract][Full Text] [Related]
36. Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E. Millar JS; Lassman ME; Thomas T; Ramakrishnan R; Jumes P; Dunbar RL; deGoma EM; Baer AL; Karmally W; Donovan DS; Rafeek H; Wagner JA; Holleran S; Obunike J; Liu Y; Aoujil S; Standiford T; Gutstein DE; Ginsberg HN; Rader DJ; Reyes-Soffer G J Lipid Res; 2017 Jun; 58(6):1214-1220. PubMed ID: 28314859 [TBL] [Abstract][Full Text] [Related]
37. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia. Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286 [TBL] [Abstract][Full Text] [Related]
38. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634 [TBL] [Abstract][Full Text] [Related]
39. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Attman PO; Alaupovic P Nephron; 1991; 57(4):401-10. PubMed ID: 2046821 [TBL] [Abstract][Full Text] [Related]
40. Relationship between plasma lipid concentrations and HDL subclasses. Yang Y; Yan B; Fu M; Xu Y; Tian Y Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]